Opus Genetics IRD EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Opus Genetics’s reported figures.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's EBIT?
- Opus Genetics (IRD) reported EBIT of -$14.36M in Q1 2026.
- How has Opus Genetics's EBIT changed year-over-year?
- Opus Genetics's EBIT decreased by 44.7% year-over-year, from -$9.93M to -$14.36M.
- What is the long-term trend for Opus Genetics's EBIT?
- Over 4 years (2021 to 2025), Opus Genetics's EBIT has grown at a 14.2% compound annual growth rate (CAGR), from -$22.71M to -$38.6M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.